Disable Preloader

Juggernaut Capital Partners Acquires Seven Over-the-Counter Brands for New Platform Investment

The new OTC platform presents an opportunity for Juggernaut to invest in market-leading OTC pharmaceutical brands

Pittsburgh, PA – October 2, 2020 – Juggernaut Capital Partners, in partnership with Kelso & Company, created Foundation Consumer Brands (“FCB”) to acquire a portfolio of seven over-the-counter (“OTC”) pharmaceutical brands from GlaxoSmithKline Consumer Healthcare. This diverse portfolio of products includes Breathe Right® Nasal Strips, the world’s #1 nasal strip, and Children’s Dimetapp®, the #1 pharmacist-recommended brand for children’s cough and cold products, as well as Anbesol®, Alavert®, Dristan®, Primatene Tablets® and FiberCon®. FCB entered into a management services contract with Foundation Consumer Healthcare (“FCH”) an existing portfolio company of Juggernaut Capital Partners and an international sales, marketing and distribution contract with Ceuta Healthcare Group, an existing portfolio company of Juggernaut Capital Partners.

“As the team behind making FCH one of the fastest-growing OTC healthcare companies, we are qualified to drive the growth of these trusted brands,” said Greg Bradley, President and CEO of Foundation.

Known for breathing new life into long-standing products, FCH is committed to using the same model with these seven new brands.

“We will invest significant resources to drive growth and look forward to leveraging our collective industry expertise to maximize the potential of these brands,” said Bradley.

The management team is comprised of industry leaders with unparalleled experience in the development, marketing and commercialization of prescription and OTC medicines.

About Juggernaut Capital Partners

Juggernaut Capital Partners is a leading private equity firm focusing on lower middle market companies primarily in the consumer and business services sectors. Juggernaut has a family of funds representing over $1 billion of capital commitments and is currently investing out of Juggernaut Capital Partners IV, L.P .

For more information on Juggernaut Capital Partners, please visit www.juggernautcap.com.